Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans.

Martinez FJ, Guillotte-Blisnick M, Huon C, England P, Popovici J, Laude H, Arowas L, Ungeheuer MN, Reimer JM, Carter D, Reed S, Mukherjee P, Chauhan VS, Chitnis CE

Open source

DOI: 10.1038/s41598-023-40043-6
Published: 2023 Aug 25
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-023-40043-6,
  title = {Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans.},
  author = {Martinez FJ and Guillotte-Blisnick M and Huon C and England P and Popovici J and Laude H and Arowas L and Ungeheuer MN and Reimer JM and Carter D and Reed S and Mukherjee P and Chauhan VS and Chitnis CE},
  year = {2023},
  journal = {Scientific reports},
  doi = {10.1038/s41598-023-40043-6},
  url = {https://doi.org/10.1038/s41598-023-40043-6}
}

RIS

TY  - JOUR
TI  - Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans.
AU  - Martinez FJ
AU  - Guillotte-Blisnick M
AU  - Huon C
AU  - England P
AU  - Popovici J
AU  - Laude H
AU  - Arowas L
AU  - Ungeheuer MN
AU  - Reimer JM
AU  - Carter D
AU  - Reed S
AU  - Mukherjee P
AU  - Chauhan VS
AU  - Chitnis CE
PY  - 2023
JO  - Scientific reports
DO  - 10.1038/s41598-023-40043-6
UR  - https://doi.org/10.1038/s41598-023-40043-6
ER  -

APA

FJ, M., M, G., C, H., P, E., J, P., H, L., L, A., MN, U., JM, R., D, C., S, R., P, M., VS, C., & CE, C. (2023). Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans.. Scientific reports. https://doi.org/10.1038/s41598-023-40043-6

Source records

pubmed · retrieved 2026-09-26T05:11:12.634Z